Proportions of Biologic Discontinuation Among Psoriasis Patients With Metabolic Comorbidities.
Clinton W EnosVanessa L RamosRobert R McLeanTin-Chi LinNicole FosterBlessing DubeAbby S Van VoorheesPublished in: Journal of psoriasis and psoriatic arthritis (2022)
Comorbid disease status, especially obesity and DM, should be assessed at biologic initiation as it may predict a less optimal clinical outcome.